SG10201800447UA - Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation - Google Patents
Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparationInfo
- Publication number
- SG10201800447UA SG10201800447UA SG10201800447UA SG10201800447UA SG10201800447UA SG 10201800447U A SG10201800447U A SG 10201800447UA SG 10201800447U A SG10201800447U A SG 10201800447UA SG 10201800447U A SG10201800447U A SG 10201800447UA SG 10201800447U A SG10201800447U A SG 10201800447UA
- Authority
- SG
- Singapore
- Prior art keywords
- granules
- rifapentine
- isoniazid
- preparation
- pharmaceutical composition
- Prior art date
Links
- 239000008187 granular material Substances 0.000 title 2
- 230000002365 anti-tubercular Effects 0.000 title 1
- 229960003350 isoniazid Drugs 0.000 title 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 title 1
- 229960002599 rifapentine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3341CH2013 | 2013-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201800447UA true SG10201800447UA (en) | 2018-02-27 |
Family
ID=51211797
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510730UA SG11201510730UA (en) | 2013-07-26 | 2014-07-22 | Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
| SG10201800447UA SG10201800447UA (en) | 2013-07-26 | 2014-07-22 | Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510730UA SG11201510730UA (en) | 2013-07-26 | 2014-07-22 | Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20160158157A1 (es) |
| EP (1) | EP3024443A1 (es) |
| JP (1) | JP6461142B2 (es) |
| CN (1) | CN105407875A (es) |
| AU (1) | AU2014295098B2 (es) |
| CA (1) | CA2918827A1 (es) |
| CL (1) | CL2016000182A1 (es) |
| EC (1) | ECSP16005208A (es) |
| HK (1) | HK1218862A1 (es) |
| IL (1) | IL243368A0 (es) |
| MX (1) | MX2016001154A (es) |
| PE (1) | PE20160520A1 (es) |
| PH (1) | PH12016500120A1 (es) |
| RU (1) | RU2682178C2 (es) |
| SG (2) | SG11201510730UA (es) |
| TW (1) | TWI651084B (es) |
| WO (1) | WO2015011161A1 (es) |
| ZA (1) | ZA201600109B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2694056C2 (ru) | 2013-07-26 | 2019-07-09 | Санофи | Противотуберкулезная стабильная фармацевтическая композиция в форме диспергируемой таблетки, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления |
| CA2918828A1 (en) | 2013-07-26 | 2015-01-29 | Sanofi | Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation |
| CN115944638A (zh) * | 2022-12-26 | 2023-04-11 | 卓和药业集团股份有限公司 | 一种利福喷丁和左氧氟沙星的复方双层片 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1217912A (zh) * | 1997-11-26 | 1999-06-02 | 岑冠新 | 复方利福喷丁制剂及制备方法 |
| HUP0203451A3 (en) * | 2000-08-09 | 2004-05-28 | Panacea Biotec Ltd | Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| WO2002087547A1 (en) * | 2001-04-27 | 2002-11-07 | Lupin Limited | An improved process for preparation of four-drug anti-tubercular fixed dose combination |
| US20050059719A1 (en) * | 2003-09-16 | 2005-03-17 | Badawy Sherif Ibrahim Farag | Solid dosage formulation containing a Factor Xa inhibitor and method |
| US7803838B2 (en) * | 2004-06-04 | 2010-09-28 | Forest Laboratories Holdings Limited | Compositions comprising nebivolol |
| US20090295921A1 (en) * | 2005-10-12 | 2009-12-03 | Pioneer Corporation | Vehicle-mounted photographing device and method of measuring photographable range of vehicle-mounted camera |
| CN1857280A (zh) * | 2006-04-11 | 2006-11-08 | 济南帅华医药科技有限公司 | 一种复方抗结核药物缓释制剂 |
| KR101197277B1 (ko) * | 2009-02-05 | 2012-11-05 | (주) 벡스코아 | 경구용 결핵의 치료용 또는 예방용 고형 제형 |
| US8470365B2 (en) * | 2010-07-29 | 2013-06-25 | Taiwan Biotech Co., Ltd. | Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom |
-
2014
- 2014-07-22 WO PCT/EP2014/065761 patent/WO2015011161A1/en active Application Filing
- 2014-07-22 JP JP2016528509A patent/JP6461142B2/ja active Active
- 2014-07-22 SG SG11201510730UA patent/SG11201510730UA/en unknown
- 2014-07-22 US US14/906,876 patent/US20160158157A1/en not_active Abandoned
- 2014-07-22 CA CA2918827A patent/CA2918827A1/en not_active Withdrawn
- 2014-07-22 CN CN201480041953.0A patent/CN105407875A/zh active Pending
- 2014-07-22 AU AU2014295098A patent/AU2014295098B2/en not_active Revoked
- 2014-07-22 PE PE2016000096A patent/PE20160520A1/es unknown
- 2014-07-22 RU RU2016106384A patent/RU2682178C2/ru not_active IP Right Cessation
- 2014-07-22 SG SG10201800447UA patent/SG10201800447UA/en unknown
- 2014-07-22 EP EP14741646.5A patent/EP3024443A1/en not_active Withdrawn
- 2014-07-22 MX MX2016001154A patent/MX2016001154A/es unknown
- 2014-07-24 TW TW103125376A patent/TWI651084B/zh active
-
2015
- 2015-12-28 IL IL243368A patent/IL243368A0/en unknown
-
2016
- 2016-01-06 ZA ZA2016/00109A patent/ZA201600109B/en unknown
- 2016-01-19 PH PH12016500120A patent/PH12016500120A1/en unknown
- 2016-01-22 CL CL2016000182A patent/CL2016000182A1/es unknown
- 2016-02-05 EC ECIEPI20165208A patent/ECSP16005208A/es unknown
- 2016-06-15 HK HK16106877.7A patent/HK1218862A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1218862A1 (zh) | 2017-03-17 |
| US20160158157A1 (en) | 2016-06-09 |
| EP3024443A1 (en) | 2016-06-01 |
| JP2016539109A (ja) | 2016-12-15 |
| JP6461142B2 (ja) | 2019-01-30 |
| IL243368A0 (en) | 2016-02-29 |
| CA2918827A1 (en) | 2015-01-29 |
| TWI651084B (zh) | 2019-02-21 |
| RU2682178C2 (ru) | 2019-03-15 |
| RU2016106384A3 (es) | 2018-05-31 |
| PH12016500120A1 (en) | 2016-04-25 |
| RU2016106384A (ru) | 2017-08-29 |
| TW201605442A (zh) | 2016-02-16 |
| SG11201510730UA (en) | 2016-01-28 |
| CL2016000182A1 (es) | 2016-06-24 |
| ECSP16005208A (es) | 2017-02-24 |
| AU2014295098A1 (en) | 2016-02-11 |
| MX2016001154A (es) | 2016-04-29 |
| WO2015011161A1 (en) | 2015-01-29 |
| CN105407875A (zh) | 2016-03-16 |
| PE20160520A1 (es) | 2016-05-31 |
| AU2014295098B2 (en) | 2019-07-11 |
| ZA201600109B (en) | 2017-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2815746A4 (en) | SAPONIN NANOMIZELES, MANUFACTURING METHOD, APPLICATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF | |
| IL271352B (en) | A pharmaceutical preparation containing a derivative of glutarimide and its use in the treatment of eosinophilic diseases | |
| HK1221649A1 (zh) | 包含乙酰水楊酸和氯吡格雷的藥物片劑 | |
| HK1214519A1 (zh) | 雙用途硫酸鹽口服藥物組合物片劑及其使用方法 | |
| EP2995308A4 (en) | ANTI-HYPOXIC PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| IL243227A0 (en) | History of diaminocyclopentane carboxamide, their preparation and pharmaceutical preparations containing them | |
| PT3102187T (pt) | Composições farmacêuticas estáveis contendo sitagliptina sob a forma de comprimidos de libertação imediata | |
| HK1222337A1 (zh) | 用於施加藥物活性成分或化妝品活性成分的局部組合物和載體 | |
| HK1218862A1 (zh) | 包含異煙肼顆粒和利福噴汀顆粒的呈包衣片劑形式的抗結核病的穩定的藥物組合物及其製備方法 | |
| EP3311809A4 (en) | USE OF A PHARMACEUTICAL COMPOSITION IN THE PREPARATION OF A MEDICAMENT FOR PROMOTING CHONDROCYTE PRODUCTION | |
| HK1218861A1 (zh) | 包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法 | |
| GB201307082D0 (en) | Pharmaceutical composition comprising 15-HETrE and methods of using the same | |
| HUP1600414A2 (hu) | Bisoprololt és ramiprilt tartalmazó stabil kombinációs gyógyszerkészítmény | |
| MX2016006742A (es) | Composicion farmaceutica. | |
| HRP20180781T1 (hr) | Farmaceutski pripravak koji sadržava lidipidipin i proces pripreme | |
| HK1219886A1 (zh) | 帶包衣的去氧腎上腺素顆粒及其在藥物製劑中的用途 | |
| TH1601000296A (th) | องค์ประกอบทางเภสัชกรรมที่เสถียรซึ่งต้านวัณโรคในรูปของยาเม็ดแบนชนิดที่แตกตัว อย่างรวดเร็วซึ่งประกอบรวมด้วยแกรนูลของไอโซไนอาซิดและแกรนูลของ ไรฟาเพนทีน และกระบวนการเตรียมของมัน |